Literature DB >> 35501488

Phage nanoparticle as a carrier for controlling fungal infection.

Songbai Xu1, Guangxin Zhang2, Meng Wang3, Tie Lin4, Wei Liu2, Yicun Wang5.   

Abstract

A mass of nanocarriers have been exploited and utilized for prevention of fungi, including organic nanomaterials, inorganic nanoparticles, polypeptides, and viruses. Due to biological safety and flexible genetic engineering property, bacteriophages, as bionanoparticles, are widely used in the diagnosis and treatment of microorganisms, which can be easily loaded with proteins and drugs. In particular, random DNAs can be inserted into the genome of phage by phage display technology, and it is possible to obtain the peptide/antibody targeting fungi from phage library. Meanwhile, phages displaying specific peptides are able to conjugate with other nanoparticles, which have both characteristics of peptides and nanomaterials, and have been used for precise detection of fungi. Additionally, phage nanomaterials as carriers can reduce the toxicity of drugs, increase the time of drug circulation, stimulate the immune response, and have an anti-fungal effect by itself. In this review, we summarize the recent applications of bacteriophages on the study of fungi. The improvement of our understanding of bacteriophage will supply new tools for controlling fungal infections. These phage libraries were used to pan the specific peptides for diagnosis, prevention, and treatment of fungi. KEY POINTS: • System fungal infection has no significant clinical symptoms; it is important to develop vaccine, diagnosis, and therapeutic agents to reduce mortality; phage is an ideal carrier for vaccine and drug to stimulate immune response and improve the efficiency of drug, and also can improve the sensitivity of detection • This review summarized recent studies on phage-based fungal vaccine and threw light on the developing therapeutic phage in the treatment of fungal infection.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Fungi; Nanoparticle; Phage; Therapy; Vaccine; Vector

Mesh:

Substances:

Year:  2022        PMID: 35501488     DOI: 10.1007/s00253-022-11932-z

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  3 in total

Review 1.  Vaccines for fungal infections.

Authors:  Urvashi Tiwari; Shukla Das; Mukta Tandon; V G Ramachandran; Rumpa Saha
Journal:  Natl Med J India       Date:  2015 Jan-Feb       Impact factor: 0.537

Review 2.  Common invasive fungal diseases: an overview of invasive candidiasis, aspergillosis, cryptococcosis, and Pneumocystis pneumonia.

Authors:  Yvonne Schmiedel; Stephan Zimmerli
Journal:  Swiss Med Wkly       Date:  2016-02-22       Impact factor: 2.193

3.  Phenotypic and functional profile of Th17 and Treg cells in allergic fungal sinusitis.

Authors:  Gargi Rai; Shukla Das; Mohammad Ahmad Ansari; Praveen Kumar Singh; Neelima Gupta; Sonal Sharma; Naseem Akhter; Vishnampettai G Ramachandran; Shafiul Haque; Sajad Ahmad Dar
Journal:  Int Immunopharmacol       Date:  2018-02-22       Impact factor: 4.932

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.